Overview
Peter Yang is a Hematologist in Danvers, Massachusetts. Dr. Yang is highly rated in 10 conditions, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer, Myelodysplastic Syndrome (MDS), Essential Thrombocythemia, and Non-Muscle Invasive Bladder Cancer.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
102 Endicott St, Danvers, MA 01923
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Massachusetts General Hospital
David Kuter is a Hematologist in Boston, Massachusetts. Dr. Kuter is highly rated in 42 conditions, according to our data. His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Thrombocytopenia, Autoimmune Hemolytic Anemia, and Splenectomy.
Dana-Farber Cancer Institute
Steven Dubois is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Dubois is highly rated in 11 conditions, according to our data. His top areas of expertise are Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.
Dana-Farber Cancer Institute
Corey Cutler is a Hematologist in Boston, Massachusetts. Dr. Cutler is highly rated in 23 conditions, according to our data. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft.
Frequently Asked Questions about Dr. Peter Yang
How do I make an appointment with Dr. Peter Yang?
You can book an appointment with Dr. Peter Yang by calling their office at 978-882-6060. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Peter Yang a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter Yang is classified as an Distinguished expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Peter Yang specialize in?
While Dr. Peter Yang is a Hematology, they have specific expertise in Muscle Invasive Bladder Cancer, Myelodysplastic Syndrome (MDS), and Essential Thrombocythemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Peter Yang participate in research or clinical trials?
Yes. Dr. Peter Yang has published 11 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Peter Yang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Peter Yang accept my insurance?
Dr. Peter Yang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 978-882-6060 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Yang isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- Adult Immune ThrombocytopeniaDr. Yang isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Essential ThrombocythemiaDr. Yang isAdvanced. Learn about Essential Thrombocythemia.
- Hemangioma Thrombocytopenia Syndrome
- Immune Thrombocytopenic Purpura (ITP)
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Yang isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Yang isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Yang isExperienced. Learn about Anemia.